24.04.2022, 844 Zeichen

Valneva: Albumedix is expanding its existing collaboration with Austrian/French  Valneva, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need.  This announcement comes on the back of the recent approval of Valneva´s inactivated COVID-19 vaccine (VLA2001) by MHRA, for which Valneva signed an agreement in November 2021 with the European Commission to supply up to 60 million doses over two years, as well as announcing an advance purchase agreement with the Kingdom of Bahrain in December 2021 for the supply of one million doses. Albumedix Recombumin rHA is an essential component in VLA2001, used in the manufacturing process and final formulation of the vaccine.
Valneva: weekly performance: -8.08%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (18/04/2022)

Christian Drastil: Wiener Börse Plausch

Zertifikate Party Österreich: Marianne Kögel, Raiffeisen Zertifikate, zu Award-Einreichungen (noch 14 Tage bis zum 20. Zertifikate Award 2026)

Bildnachweis

Aktien auf dem Radar:Austriacard Holdings AG, Bajaj Mobility AG, AT&S, Zumtobel, Amag, CPI Europe AG, Rosgix, UBM, Kapsch TrafficCom, ATX, ATX Prime, ATX TR, ATX NTR, Erste Group, EVN, OMV, VIG, CA Immo, Reploid Group AG, Hutter & Schrantz Stahlbau, Porr, Polytec Group, Wiener Privatbank, Rosenbauer, Semperit, EuroTeleSites AG, Österreichische Post, Telekom Austria.

---